Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Oramed Pharmaceuticals  / Equity Bottom-Up

<ul><li>ORMP is leveraging its strong balance sheet to invest in early stage companies, primarily focusing on the medical & biopharma space.</li><li> ORMP has substantial liquidity as it both advances its oral drug delivery platform and pursues strategic opportunities, including strategic investments.</li><li>The company received ~$27m on its Scilex investment in 3Q25, with the principal on the Scilex investment now fully repaid.</li></ul>

ORMP is leveraging its strong balance sheet to invest in early stage companies, primarily focusing on the medical & biopharma space. ORMP has substantial liquidity as it both advances its oral drug delivery platform and pursues strategic opportunities, including strategic investments.The company received ~$27m on its Scilex investment in 3Q25, with the principal on the Scilex investment now fully repaid.

Oramed Pharmaceuticals

ORMP: Advancing Clinical Activities